 | • レポートコード：GIR-105X12637 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、核医学用放射性同位元素のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。核医学用放射性同位元素の種類別市場規模（タリウム-201（Tl-201）、ヨウ素（I-123）、フッ素-18、ルビジウム-82（Rb-82）、その他）、用途別市場規模（腫瘍、心臓病、リンパ腫、甲状腺、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・核医学用放射性同位元素の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Agfa-Gevaert Group、Braco、Cardiarc、Cardinal Health、CMR Naviscan (Gamma Medica Inc.)、Curium、Digirad、GE Healthcare、Nordion (Canada)、NTP Radioisotopes SOC、Positron、Segami、Siemens Healthcare ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：タリウム-201（Tl-201）、ヨウ素（I-123）、フッ素-18、ルビジウム-82（Rb-82）、その他 ・用途別分析2016年-2026年：腫瘍、心臓病、リンパ腫、甲状腺、その他 ・核医学用放射性同位元素の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・核医学用放射性同位元素のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・核医学用放射性同位元素のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・核医学用放射性同位元素の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・核医学用放射性同位元素の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nuclear Medicine Radioisotopes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nuclear Medicine Radioisotopes size is estimated to be xx million in 2020 from USD 3539.9 million in 2019, with a change of XX% between 2019 and 2020. The global Nuclear Medicine Radioisotopes market size is expected to grow at a CAGR of 3.2% for the next five years.
Market segmentation
Nuclear Medicine Radioisotopes market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Market segment by Application can be divided into
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
The key market players for global Nuclear Medicine Radioisotopes market are listed below:
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Nuclear Medicine Radioisotopes Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Medicine Radioisotopes Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Thallium-201 (Tl-201)
1.2.3 Iodine (I-123)
1.2.4 Fluorine-18
1.2.5 Rubidium-82 (Rb-82)
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Medicine Radioisotopes Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Tumor
1.3.3 Heart Disease
1.3.4 Lymphoma
1.3.5 Thyroid Gland
1.3.6 Other
1.4 Global Nuclear Medicine Radioisotopes Market Size & Forecast
1.4.1 Global Nuclear Medicine Radioisotopes Sales in Value (2016-2026))
1.4.2 Global Nuclear Medicine Radioisotopes Sales in Volume (2016-2026)
1.4.3 Global Nuclear Medicine Radioisotopes Price by Type (2016-2026) & (USD/Unit)
1.5 Global Nuclear Medicine Radioisotopes Production Capacity Analysis
1.5.1 Global Nuclear Medicine Radioisotopes Total Production Capacity (2016-2026)
1.5.2 Global Nuclear Medicine Radioisotopes Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nuclear Medicine Radioisotopes Market Drivers
1.6.2 Nuclear Medicine Radioisotopes Market Restraints
1.6.3 Nuclear Medicine Radioisotopes Trends Analysis
2 Manufacturers Profiles
2.1 Agfa-Gevaert Group
2.1.1 Agfa-Gevaert Group Details
2.1.2 Agfa-Gevaert Group Major Business
2.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product and Services
2.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Braco
2.2.1 Braco Details
2.2.2 Braco Major Business
2.2.3 Braco Nuclear Medicine Radioisotopes Product and Services
2.2.4 Braco Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Cardiarc
2.3.1 Cardiarc Details
2.3.2 Cardiarc Major Business
2.3.3 Cardiarc Nuclear Medicine Radioisotopes Product and Services
2.3.4 Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Cardinal Health
2.4.1 Cardinal Health Details
2.4.2 Cardinal Health Major Business
2.4.3 Cardinal Health Nuclear Medicine Radioisotopes Product and Services
2.4.4 Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 CMR Naviscan (Gamma Medica Inc.)
2.5.1 CMR Naviscan (Gamma Medica Inc.) Details
2.5.2 CMR Naviscan (Gamma Medica Inc.) Major Business
2.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product and Services
2.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Curium
2.6.1 Curium Details
2.6.2 Curium Major Business
2.6.3 Curium Nuclear Medicine Radioisotopes Product and Services
2.6.4 Curium Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Digirad
2.7.1 Digirad Details
2.7.2 Digirad Major Business
2.7.3 Digirad Nuclear Medicine Radioisotopes Product and Services
2.7.4 Digirad Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Nuclear Medicine Radioisotopes Product and Services
2.8.4 GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Nordion (Canada)
2.9.1 Nordion (Canada) Details
2.9.2 Nordion (Canada) Major Business
2.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Product and Services
2.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 NTP Radioisotopes SOC
2.10.1 NTP Radioisotopes SOC Details
2.10.2 NTP Radioisotopes SOC Major Business
2.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product and Services
2.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Positron
2.11.1 Positron Details
2.11.2 Positron Major Business
2.11.3 Positron Nuclear Medicine Radioisotopes Product and Services
2.11.4 Positron Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Segami
2.12.1 Segami Details
2.12.2 Segami Major Business
2.12.3 Segami Nuclear Medicine Radioisotopes Product and Services
2.12.4 Segami Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Siemens Healthcare
2.13.1 Siemens Healthcare Details
2.13.2 Siemens Healthcare Major Business
2.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Product and Services
2.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Nuclear Medicine Radioisotopes Sales by Manufacturer
3.1 Global Nuclear Medicine Radioisotopes Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nuclear Medicine Radioisotopes Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nuclear Medicine Radioisotopes
3.4 Market Concentration Rate
3.4.1 Top 3 Nuclear Medicine Radioisotopes Manufacturer Market Share
3.4.2 Top 6 Nuclear Medicine Radioisotopes Manufacturer Market Share
3.5 Global Nuclear Medicine Radioisotopes Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nuclear Medicine Radioisotopes Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nuclear Medicine Radioisotopes Market Size by Region
4.1.1 Global Nuclear Medicine Radioisotopes Sales in Volume by Region (2016-2026)
4.1.2 Global Nuclear Medicine Radioisotopes Revenue by Region (2016-2026)
4.2 North America Nuclear Medicine Radioisotopes Revenue (2016-2026)
4.3 Europe Nuclear Medicine Radioisotopes Revenue (2016-2026)
4.4 Asia-Pacific Nuclear Medicine Radioisotopes Revenue (2016-2026)
4.5 South America Nuclear Medicine Radioisotopes Revenue (2016-2026)
4.6 Middle East and Africa Nuclear Medicine Radioisotopes Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nuclear Medicine Radioisotopes Sales in Volume by Type (2016-2026)
5.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2016-2026)
5.3 Global Nuclear Medicine Radioisotopes Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nuclear Medicine Radioisotopes Sales in Volume by Application (2016-2026)
6.2 Global Nuclear Medicine Radioisotopes Revenue by Application (2016-2026)
6.3 Global Nuclear Medicine Radioisotopes Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nuclear Medicine Radioisotopes Sales by Type (2016-2026)
7.2 North America Nuclear Medicine Radioisotopes Sales by Application (2016-2026)
7.3 North America Nuclear Medicine Radioisotopes Market Size by Country
7.3.1 North America Nuclear Medicine Radioisotopes Sales in Volume by Country (2016-2026)
7.3.2 North America Nuclear Medicine Radioisotopes Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nuclear Medicine Radioisotopes Sales by Type (2016-2026)
8.2 Europe Nuclear Medicine Radioisotopes Sales by Application (2016-2026)
8.3 Europe Nuclear Medicine Radioisotopes Market Size by Country
8.3.1 Europe Nuclear Medicine Radioisotopes Sales in Volume by Country (2016-2026)
8.3.2 Europe Nuclear Medicine Radioisotopes Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales by Type (2016-2026)
9.2 Asia-Pacific Nuclear Medicine Radioisotopes Sales by Application (2016-2026)
9.3 Asia-Pacific Nuclear Medicine Radioisotopes Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nuclear Medicine Radioisotopes Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nuclear Medicine Radioisotopes Sales by Type (2016-2026)
10.2 South America Nuclear Medicine Radioisotopes Sales by Application (2016-2026)
10.3 South America Nuclear Medicine Radioisotopes Market Size by Country
10.3.1 South America Nuclear Medicine Radioisotopes Sales in Volume by Country (2016-2026)
10.3.2 South America Nuclear Medicine Radioisotopes Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Type (2016-2026)
11.2 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Application (2016-2026)
11.3 Middle East & Africa Nuclear Medicine Radioisotopes Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine Radioisotopes Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nuclear Medicine Radioisotopes Typical Distributors
12.3 Nuclear Medicine Radioisotopes Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nuclear Medicine Radioisotopes Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nuclear Medicine Radioisotopes Revenue by Application, (USD Million), 2021-2026
Table 3. Agfa-Gevaert Group Basic Information, Manufacturing Base and Competitors
Table 4. Agfa-Gevaert Group Major Business
Table 5. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product and Services
Table 6. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Braco Basic Information, Manufacturing Base and Competitors
Table 8. Braco Major Business
Table 9. Braco Nuclear Medicine Radioisotopes Product and Services
Table 10. Braco Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cardiarc Basic Information, Manufacturing Base and Competitors
Table 12. Cardiarc Major Business
Table 13. Cardiarc Nuclear Medicine Radioisotopes Product and Services
Table 14. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 16. Cardinal Health Major Business
Table 17. Cardinal Health Nuclear Medicine Radioisotopes Product and Services
Table 18. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CMR Naviscan (Gamma Medica Inc.) Basic Information, Manufacturing Base and Competitors
Table 20. CMR Naviscan (Gamma Medica Inc.) Major Business
Table 21. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product and Services
Table 22. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Curium Basic Information, Manufacturing Base and Competitors
Table 24. Curium Major Business
Table 25. Curium Nuclear Medicine Radioisotopes Product and Services
Table 26. Curium Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Digirad Basic Information, Manufacturing Base and Competitors
Table 28. Digirad Major Business
Table 29. Digirad Nuclear Medicine Radioisotopes Product and Services
Table 30. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. GE Healthcare Major Business
Table 33. GE Healthcare Nuclear Medicine Radioisotopes Product and Services
Table 34. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Nordion (Canada) Basic Information, Manufacturing Base and Competitors
Table 36. Nordion (Canada) Major Business
Table 37. Nordion (Canada) Nuclear Medicine Radioisotopes Product and Services
Table 38. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. NTP Radioisotopes SOC Basic Information, Manufacturing Base and Competitors
Table 40. NTP Radioisotopes SOC Major Business
Table 41. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product and Services
Table 42. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Positron Basic Information, Manufacturing Base and Competitors
Table 44. Positron Major Business
Table 45. Positron Nuclear Medicine Radioisotopes Product and Services
Table 46. Positron Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Segami Basic Information, Manufacturing Base and Competitors
Table 48. Segami Major Business
Table 49. Segami Nuclear Medicine Radioisotopes Product and Services
Table 50. Segami Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 52. Siemens Healthcare Major Business
Table 53. Siemens Healthcare Nuclear Medicine Radioisotopes Product and Services
Table 54. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Nuclear Medicine Radioisotopes Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Nuclear Medicine Radioisotopes Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Nuclear Medicine Radioisotopes, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Nuclear Medicine Radioisotopes Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Nuclear Medicine Radioisotopes Production Site of Key Manufacturer
Table 60. Global Nuclear Medicine Radioisotopes Sales by Region (2016-2021e) & (K Units)
Table 61. Global Nuclear Medicine Radioisotopes Sales by Region (2021-2026) & (K Units)
Table 62. Global Nuclear Medicine Radioisotopes Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Nuclear Medicine Radioisotopes Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Nuclear Medicine Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 65. Global Nuclear Medicine Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 66. Global Nuclear Medicine Radioisotopes Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Nuclear Medicine Radioisotopes Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Nuclear Medicine Radioisotopes Price by Type (2016-2021e) & (USD/Unit)
Table 69. Global Nuclear Medicine Radioisotopes Price by Type (2021-2026) & (USD/Unit)
Table 70. Global Nuclear Medicine Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 71. Global Nuclear Medicine Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 72. Global Nuclear Medicine Radioisotopes Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Nuclear Medicine Radioisotopes Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Nuclear Medicine Radioisotopes Price by Application (2016-2021e) & (USD/Unit)
Table 75. Global Nuclear Medicine Radioisotopes Price by Application (2021-2026) & (USD/Unit)
Table 76. North America Nuclear Medicine Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 77. North America Nuclear Medicine Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 78. North America Nuclear Medicine Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Nuclear Medicine Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Nuclear Medicine Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 81. North America Nuclear Medicine Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 82. North America Nuclear Medicine Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 83. North America Nuclear Medicine Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 84. Europe Nuclear Medicine Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Nuclear Medicine Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 86. Europe Nuclear Medicine Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Nuclear Medicine Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Nuclear Medicine Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Nuclear Medicine Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 90. Europe Nuclear Medicine Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Nuclear Medicine Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Nuclear Medicine Radioisotopes Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Nuclear Medicine Radioisotopes Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Nuclear Medicine Radioisotopes Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Nuclear Medicine Radioisotopes Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Nuclear Medicine Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Nuclear Medicine Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Nuclear Medicine Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Nuclear Medicine Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 100. South America Nuclear Medicine Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 101. South America Nuclear Medicine Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 102. South America Nuclear Medicine Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Nuclear Medicine Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Nuclear Medicine Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 105. South America Nuclear Medicine Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 106. South America Nuclear Medicine Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 107. South America Nuclear Medicine Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Nuclear Medicine Radioisotopes Typical Distributors
Table 119. Nuclear Medicine Radioisotopes Typical Customers
List of Figures
Figure 1. Nuclear Medicine Radioisotopes Picture
Figure 2. Global Nuclear Medicine Radioisotopes Sales Market Share by Type in 2020
Figure 3. Thallium-201 (Tl-201)
Figure 4. Iodine (I-123)
Figure 5. Fluorine-18
Figure 6. Rubidium-82 (Rb-82)
Figure 7. Other
Figure 8. Global Nuclear Medicine Radioisotopes Sales Market Share by Application in 2020
Figure 9. Tumor
Figure 10. Heart Disease
Figure 11. Lymphoma
Figure 12. Thyroid Gland
Figure 13. Other
Figure 14. Global Nuclear Medicine Radioisotopes Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Nuclear Medicine Radioisotopes Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Nuclear Medicine Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Nuclear Medicine Radioisotopes Sales (2016-2026) & (K Units)
Figure 36. Global Nuclear Medicine Radioisotopes Production Capacity (2016-2026) & (K Units)
Figure 37. Global Nuclear Medicine Radioisotopes Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Nuclear Medicine Radioisotopes Market Drivers
Figure 39. Nuclear Medicine Radioisotopes Market Restraints
Figure 40. Nuclear Medicine Radioisotopes Market Trends
Figure 41. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturer in 2020
Figure 42. Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturer in 2020
Figure 43. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Nuclear Medicine Radioisotopes Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Nuclear Medicine Radioisotopes Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2016-2026)
Figure 47. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2016-2026)
Figure 48. North America Nuclear Medicine Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 49. Europe Nuclear Medicine Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Nuclear Medicine Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 51. South America Nuclear Medicine Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Nuclear Medicine Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 53. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2026)
Figure 54. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2016-2026)
Figure 55. Global Nuclear Medicine Radioisotopes Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2026)
Figure 57. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2016-2026)
Figure 58. Global Nuclear Medicine Radioisotopes Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2026)
Figure 60. North America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 61. North America Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2026)
Figure 62. North America Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2026)
Figure 63. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2026)
Figure 64. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 65. Europe Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2026)
Figure 66. Europe Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2026)
Figure 71. South America Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2026)
Figure 72. South America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 73. South America Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2026)
Figure 74. South America Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の治療用放射性同位元素市場 2021：企業別、地域別、種類・用途別 The Therapeutic Radioisotopes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界の核医学システム市場 2021：企業別、地域別、種類・用途別 The Nuclear Medicine System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の核医学用機器市場 2021：企業別、地域別、種類・用途別 The Nuclear Medicine Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の診断用放射性同位元素市場 2021：企業別、地域別、種類・用途別 The Diagnostic Radioisotopes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 原子炉の建設の世界市場予測 2023年：メーカー別、地域別、種類・用途別 A nuclear reactor is a device used to initiate and control sustained nuclear chain reactions. Nuclear reactors are deployed in nuclear power plants to generate electricity and for the propulsion of ships. Heat emitted from nuclear fission is passed to the working fluid, such as water or gas, to run …